HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Hanon Selected Research

Methyclothiazide

7/2006[Home blood pressure monitoring in addition to office blood pressure determination is useful in patients with systolic hypertension before their inclusion into a drug trial].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Hanon Research Topics

Disease

16Hypertension (High Blood Pressure)
10/2019 - 08/2000
5Alzheimer Disease (Alzheimer's Disease)
01/2016 - 10/2003
5Dementia (Dementias)
06/2014 - 10/2001
4Cardiovascular Diseases (Cardiovascular Disease)
06/2017 - 04/2000
4Cognitive Dysfunction
06/2014 - 10/2003
4Stroke (Strokes)
06/2012 - 10/2001
3Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2014 - 10/2001
3Atherosclerosis
11/2006 - 04/2000
2Hemorrhage
09/2018 - 01/2018
2Metabolic Diseases (Metabolic Disease)
06/2018 - 06/2017
2Heart Failure
06/2012 - 12/2004
1Amyloidosis
02/2022
1Renal Insufficiency (Renal Failure)
01/2018
1Atrial Fibrillation
01/2018
1Dyslipidemias (Dyslipidemia)
06/2017
1Chronic Disease (Chronic Diseases)
06/2017
1Frontotemporal Dementia (Semantic Dementia)
01/2016
1Frailty
03/2015
1Pain (Aches)
01/2013
1Neuralgia (Stump Neuralgia)
01/2013
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2012
1Orthostatic Hypotension (Postural Hypotension)
08/2007
1Thrombosis (Thrombus)
11/2006
1Cicatrix (Scar)
11/2006
1Isolated Systolic Hypertension
07/2006
1Masked Hypertension
07/2006
1Coronary Disease (Coronary Heart Disease)
12/2004
1Cough
07/2002
1Fatigue
07/2002
1Dyspnea (Shortness of Breath)
07/2002
1Dizziness (Lightheadedness)
07/2002
1Hypercholesterolemia
08/2000
1Obesity
08/2000
1Hypertrophy
04/2000

Drug/Important Bio-Agent (IBA)

18Antihypertensive Agents (Antihypertensives)IBA
10/2019 - 08/2000
3Pharmaceutical PreparationsIBA
06/2013 - 08/2000
3CalciumIBA
01/2003 - 10/2001
2TabletsIBA
06/2017 - 10/2000
2Apolipoproteins E (ApoE)IBA
01/2016 - 09/2011
2ApolipoproteinsIBA
09/2011 - 04/2000
2LipidsIBA
11/2006 - 04/2000
2DiureticsIBA
12/2004 - 07/2002
1tafamidisIBA
02/2022
1SaltsIBA
10/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2018
1olmesartanIBA
06/2018
1DabigatranFDA Link
01/2018
1tau Proteins (tau Protein)IBA
01/2016
1MicronutrientsIBA
03/2015
1AntioxidantsIBA
03/2015
1Analgesics (Analgesic Drugs)IBA
01/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2013
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2012
1Biomarkers (Surrogate Marker)IBA
01/2012
1hydroxide ionIBA
08/2007
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
07/2006
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
07/2006
1IndapamideFDA LinkGeneric
07/2006
1MethyclothiazideFDA LinkGeneric
07/2006
1NitrendipineIBA
01/2003
1ElastinIBA
11/2001
1Cardiovascular AgentsIBA
11/2001
1Endothelins (Endothelin)IBA
08/2001
1Prazosin (Minipress)FDA LinkGeneric
10/2000
1Insulin (Novolin)FDA Link
10/2000
1Biological ProductsIBA
08/2000
1ReninIBA
08/2000
1CreatinineIBA
08/2000
1CholesterolIBA
04/2000

Therapy/Procedure

3Therapeutics
03/2008 - 08/2001
2Secondary Prevention
06/2017 - 10/2001
2Activities of Daily Living (ADL)
01/2005 - 10/2003
1Self-Testing
10/2019
1Polypharmacy
09/2018
1Mediterranean Diet
03/2015
1Ambulatory Care (Outpatient Care)
01/2013